SCHEMBL1352167

SCHEMBL1352167

CC(C)(C)N(Cc1ccc(-c2nc3c(-c4ccco4)cnc(O)c3cc2-c2ccccc2)cc1)C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CKS1B P61024 1/20 0.34
SKP1 P63208 1/20 0.34
SKP2 Q13309 1/20 0.34
LMNA P02545 2/20 0.33
CNR1 P21554 1/20 0.33
AKT1 P31749 3/20 0.33
AKT2 P31751 2/20 0.33
CACNA1B Q00975 1/20 0.33
APBA1 Q02410 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
PTPN22 Q9Y2R2 1/20 0.33
PSMB5 P28074 1/20 0.33
KDM4E B2RXH2 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1352201 0.84 AKT1 (0.34) MEN1KMT2ALMNACNR1AKT1
SCHEMBL1351411 0.83 TAAR1 (0.42) ADORA2AADORA1EGFRMAPK14
SCHEMBL1351814 0.82 NTRK1 (0.36) MEN1KMT2ALMNACNR1AKT1
Trifluoroacetic Acid SCHEMBL1352691 0.82 TAAR1 (0.37) GSK3BMEN1KMT2AAKT1AKT2
SCHEMBL12132983 0.82 HDAC1 (0.42) CKS1BSKP1SKP2AKT1AKT2
SCHEMBL1350490 0.76 AKT1 (0.41) MEN1KMT2ALMNAAKT1PSMB5
SCHEMBL1349890 0.74 DHODH (0.41) MEN1KMT2AAKT1AKT2
SCHEMBL1352166 0.74 ADK (0.42) MEN1KMT2AAKT1AKT2ADORA2A
SCHEMBL1351123 0.74 AKT1 (0.39) MEN1KMT2ALMNAAKT1AKT2
SCHEMBL1352657 0.73 AKT1 (0.38) MEN1KMT2ALMNAAKT1AKT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110288090-A1 Inhibitors of AKT Activity MERCK SHARP & DOHME CORP. 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110288090-A1 Inhibitors of AKT Activity PIK3CD, PIK3CA, PIK3CG GSK3B 36/4885MEN1 1098/4885KMT2A 1363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.